Biotech

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 02.12.2022.

#lifesciences
#biopharma
#ClinicalResearchNews
#Workforcedevelopment
#Apprenticeships
#news
#NBTintheNews
#biotech
#CRISPR
#PharmiwebNews

@NatureBiotech shared
On Nov 30, 2022
@endpts PASTE expands CRISPR toolbox by inserting large pieces of DNA #NBTintheNews via @GENbio https://t.co/B1DY1y0xxS
Open
PASTE Expands CRISPR Toolbox by Inserting Large Pieces of DNA

PASTE Expands CRISPR Toolbox by Inserting Large Pieces of DNA

PASTE, a new CRISPR-Cas9 based genome editing tool, holds potential for treating a variety of diseases caused by faulty genes.

@MassBioEd shared
On Dec 1, 2022
Thank you to @CorningLifeSci for creating this fantastic blog post about their partnership with our Biomanufacturing Technician Apprenticeship Program. Read it here: https://t.co/hhaKnOCJ0Y #Apprenticeships #Workforcedevelopment
Open
How Life Science Apprenticeships Can Launch New Careers in Biotech

How Life Science Apprenticeships Can Launch New Careers in Biotech

Life science apprenticeships could answer the projected skills shortage in the biotech industry. Learn how apprenticeships can lead to a biotech career.

@Labiotech_eu shared
On Nov 28, 2022
Aptamer Group developer of Optimer binders that enable development in life sciences industry has opened new facilities in York Science Park. 👇🏻 #biotech #lifesciences #news https://t.co/3ioFi0M4hV
Open
Aptamer opens new facilities to meet growing demand for Optimer technology

Aptamer opens new facilities to meet growing demand for Optimer technology

Aptamer Group developer of Optimer binders that enable development in life sciences industry has opened new facilities in York Science Park.

@JohnCendpts shared
On Nov 30, 2022
https://t.co/iBojLIvXG2
Open
Updated: Catalent to cut about 600 jobs in Indiana, Maryland and Texas

Updated: Catalent to cut about 600 jobs in Indiana, Maryland and Texas

Contract manufacturing company Catalent is cutting around 600 jobs in Maryland, Texas, and a major manufacturing facility in Bloomington, IN. According to a report from a local news site, ...

@BiotechWorld shared
On Dec 1, 2022
Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director https://t.co/ruVHvBxIbj
Open
Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director

Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director

Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director - read this article along with other careers information, tips and advice ...

@JohnCendpts shared
On Dec 2, 2022
https://t.co/cgbE49NKdq
Open
Sanofi's Paul Hudson is bringing cash to cover the table stakes for the Horizon M&A game

Sanofi's Paul Hudson is bringing cash to cover the table stakes for the Horizon M&A game

With the market cap on Horizon Therapeutics $HZNP pushed up to the $23 billion mark today, one of the Big Pharmas in the hunt for a major league buyout deal signaled it’s playing the M&A ...

@pharminews shared
On Dec 1, 2022
Vaxxas Appoints Doug Cubbin as Chief Financial Officer https://t.co/qznauZZrh8 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/c4H3N8lp5H
Open
Vaxxas Appoints Doug Cubbin as Chief Financial Officer

Vaxxas Appoints Doug Cubbin as Chief Financial Officer

CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced another key addition to ...

@biospace shared
On Nov 28, 2022
Many #biopharma companies raised funds in 2022, but not enough to reach their next milestone. Read on for more info. #Biopharma #LifeSciences #BioSpace https://t.co/xZdJb2x0Ow
Open
Recession Survival Strategies for Newly Public Biopharma Companies

Recession Survival Strategies for Newly Public Biopharma Companies

Many biopharma companies raised funds in 2022, but not enough to reach their next milestone. Investors have been constricting investments, so companies needing additional funding require a ...